CAMP
Price:
$3.39
Market Cap:
$72.00M
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Industry
Biotechnology
IPO Date
2024-10-11
Stock Exchange
NASDAQ
Ticker
CAMP
According to CAMP4 Therapeutics Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -0.31. This represents a change of -84.39% compared to the average of -1.99 of the last 4 quarters.
The mean historical PE Ratio of CAMP4 Therapeutics Corporation over the last ten years is -4.00. The current -0.31 PE Ratio has changed 675.10% with respect to the historical average. Over the past ten years (40 quarters), CAMP's PE Ratio was at its highest in in the August 2016 quarter at 187.19. The PE Ratio was at its lowest in in the November 2018 quarter at -177.44.
Average
-4.00
Median
-4.41
Minimum
-53.84
Maximum
23.07
Discovering the peaks and valleys of CAMP4 Therapeutics Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 279.55%
Maximum Annual PE Ratio = 23.07
Minimum Annual Increase = -333.44%
Minimum Annual PE Ratio = -53.84
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.97 | -53.80% |
| 2023 | -4.26 | -64.27% |
| 2023 | -11.91 | -1.83% |
| 2022 | -12.13 | -29.83% |
| 2021 | -17.29 | 279.55% |
| 2020 | -4.56 | -122.60% |
| 2019 | 20.15 | -11.37% |
| 2018 | 22.74 | -142.24% |
| 2017 | -53.84 | -333.44% |
| 2016 | 23.07 | -0.74% |
The current PE Ratio of CAMP4 Therapeutics Corporation (CAMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.04
5-year avg
-9.51
10-year avg
-4.00
CAMP4 Therapeutics Corporation’s PE Ratio is greater than Unicycive Therapeutics, Inc. (-3.51), greater than Repare Therapeutics Inc. (-1.33), greater than Vaxart, Inc. (-1.67), greater than Biomea Fusion, Inc. (-0.90), greater than MindWalk Holdings Corp. (-4.56), greater than Quince Therapeutics, Inc. (-3.43), greater than ALX Oncology Holdings Inc. (-0.63), greater than Acrivon Therapeutics, Inc. Common Stock (-1.14), greater than PMV Pharmaceuticals, Inc. (-0.82), greater than aTyr Pharma, Inc. (-1.07),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.51 | $114.80M | |
| -1.33 | $95.84M | |
| -1.67 | $88.82M | |
| -0.90 | $70.80M | |
| -4.56 | $95.54M | |
| -3.43 | $200.45M | |
| -0.63 | $74.28M | |
| -1.14 | $76.05M | |
| -0.82 | $68.11M | |
| -1.07 | $81.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CAMP4 Therapeutics Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CAMP4 Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is CAMP4 Therapeutics Corporation's PE Ratio?
How is the PE Ratio calculated for CAMP4 Therapeutics Corporation (CAMP)?
What is the highest PE Ratio for CAMP4 Therapeutics Corporation (CAMP)?
What is the 3-year average PE Ratio for CAMP4 Therapeutics Corporation (CAMP)?
What is the 5-year average PE Ratio for CAMP4 Therapeutics Corporation (CAMP)?
How does the current PE Ratio for CAMP4 Therapeutics Corporation (CAMP) compare to its historical average?